Neurobiology of stress and cocaine addiction studies on corticotropin-releasing factor in rats, monkeys, and humans

Annals of the New York Academy of Sciences

Volumn 851, Issue , 1998, Pages 371-387

  Sarnyai, Zoltán ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISERUM; COCAINE; CORTICOSTERONE; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR ANTAGONIST;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; BEHAVIOR; CONFERENCE PAPER; CONTROLLED STUDY; CORTICOTROPIN RELEASE; DOSE TIME EFFECT RELATION; DRUG DEPENDENCE; DRUG WITHDRAWAL; FOREBRAIN; HUMAN; HYPERACTIVITY; HYPOTHALAMUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNE RESPONSE; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; MONKEY; NEUROBIOLOGY; NONHUMAN; RAT; SPECIES DIFFERENCE; STRESS;

ANIMALIA; MACACA MULATTA;

EID: 0031825997     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1998.tb09011.x     Document Type: Article

References (67)

1. MENDELSON, J. H. & N. K. MELLO. 1994. Cocaine and other commonly abused drugs. In Harrison's Principles of Internal Medicine, 13th ed. K. J. Isselbacher, E. Braunwald, J. D. Wilson, J. B. Martin, A. S. Fauci & D. L. Kasper, Eds.: 2429-2433. McGraw-Hill. New York.
2. PIAZZA, P. V. & M. LE MOAL. 1996 Pathophysiological basis of vulnerability to drug abuse: Role of an interaction between stress, glucocorticoids, and dopaminergic neurons. Ann. Rev. Pharmacol. Toxicol. 36: 359-378.
3. VALE W., et al. 1981. Characterization of a 41 residue ovine hypothalamic peptide that stimulates the secretion of corticotropin and β-endorphin. Science 213: 1394-1379.
4. PETRUSZ, P. & I. MERCHENTHALER. 1992. The corticotropin-releasing factor system, In Neuroendocrinology. C. B. Nemeroff Ed.: 129-183. CRC Press. Boca Raton. FL.
5. DE SOUSA, E. B., et al. 1985. Corticortropin-releasing factor receptors are widely distributed within the rat central nervous system. An autoradiographic study. J. Neurosci. 5: 3189-3203.
6. SMITH, M. A., et al. 1986. Release of corticotropin-releasing factor from rat brain regions in vitro. Endocrinology 118: 1997-2001.
7. RIVIER, C. & W. VALE. 1987. Cocaine stimulates adrenocorticotropin (ACTH) secretion through a corticotropin-releasing factor (CRF)-mediated mechanism. Brain Res. 422: 403-406.
8. ANTONI, F. A. 1986. Hypothalamic control of adrenocorticotropin secretion: Advances since the discovery of the 41-residue corticotropin-releasing peptide. Endocr. Rev 7: 351-378.
9. SARNYAI, Z., et al. 1992. Effects of cocaine on the contents of neurohypophyseal hormones in the plasma and in different brain structures in rats. Neuropeptides 23: 27-31.
10. RIVIER, C. & S. LEE. 1994. Stimulatory effect of cocaine on ACTH secretion: Role of hypothalamus. Mol. Cell. Neurosci 5: 189-195.
11. VELDHUIS, J. D. & M. L. JOHNSON. 1986. Cluster analysis: A simple, versatile, and robust algorithm for endocrine pulse detection. Am. J. Physiol. 250: E486-E493.
12. IRANMANESH, A. et al. 1990. Intensive venous sampling paradigms disclose high frequency adrenocorticotropin release episodes in normal men. J. Clin. Endocrinol. Metab. 71: 1276-83.
13. CARNES, M., et al. 1988. Pulsatile ACTH secretion: variation with time of day and relationship to cortisol. Peptides 9: 325-331.
14. SARNYAI, Z., et al. 1995. The concordance of pulsatile ultradian release of adrenocorticotropin and cortisol in male rhesus monkeys. J. Clin. Endocrinol. Metab. 80: 54-59.
15. SARNYAI, Z., et al. 1995. Effects of cocaine and corticotropin-releasing factor (CRF) on pulsatile ACTH and cortisol release in ovariectomized rhesus monkeys. J. Clin. Endocrinol. Metab. 80: 52745-2751.
16. CARNES, M., et al. 1990. Effects of immunoneutralization of corticotropin-releasing hormone on ultradian rhythms of plasma adrenocorticotropin. Endocrinology 126: 1904-1913.
17. SARNYAI, Z., et al. 1996. Effects of cocaine on pulsatile activity of the hypothalamic-pituitary-adrenal axis in male rhesus monkeys: Behavioral and neuroendocrine correlates. J. Pharmacol. Exp. Ther. 277: 225-234.
18. MENDELSON, J. H., et al. 1992. Buprenorphine attenuates the effects of cocaine on adrenocorticotropin (ACTH) secretion and mood states in man. Neuropsychopharmacology 7: 157-162.
19. MENDELSON, J. H., et al. 1992. Acute effects of cocaine on plasma ACTH, luteinizing hormone and prolactine levels in cocaine-dependent men. J. Pharmacol. Exp. Ther. 263: 505-509.
20. TEOH, S. K., et al. 1994. Cocaine effects on pulsatile secretion of ACTH in men. J. Pharmacol. Exp.Ther. 270: 1134-1138.
21. CALOGERO, A. E., et al. (1989): Cocaine stimulates rat hypothalamic corticotropin-releasing hormone secretion in vitro. Brain Res. 505: 7-11.
22. SARNYAI, Z., et al. 1992. Critical role of endogenous corticotropin-releasing factor (CRF) in the mediation of the behavioral action of cocaine in rats. Life Sci. 51: 2019-2024.
23. TAZI, A., et al. 1987. Behavioral activation of CRF: Evidence for the involvement of the ventral forebrain. Life Sci. 41: 41-50.
24. LEE, E. H. Y. & M. J. TSAI. 1989. The hippocampus and amygdala mediate the locomotor stimulating effects of corticotropin-releasing factor in mice. Behav. Neural. Biol. 51: 412-423.
25. SWERDLOW, N. R., et al. 1986. The neural substrates for the motor-activating properties of psychomotor stimulants: A review of recent findings. Pharmacol. Biochem. Behav. 25: 233-248.
26. MATSUZAKI, I., et al. 1989. The effects of intracerebroventricularly injected corticotropin-releasing factor (CRF) on the central nervous system: Behavioral and biochemical studies. Neuropeptides 13: 147-155.
27. POST, R. M., et al. 1976. Progressive effects of cocaine on behavior and central amine metabolism in rhesus monkeys: Relationship to kindling and psychosis. Biol. Psychiatry 11: 403-419.
28. SARNYAI, Z., et al. 1993. Acute cocaine administration alters corticotropin-releasing factor (CRF)-like immunoreactivity in different rat brain regions. Brain Res. 616: 315-319.
29. DUNN, A. J. & C. W. BERRIDGE. 1990. Physiological and behavioral response to corticotropin-releasing factor administration: Is CRF a mediator of anxiety or stress responses? Brain Res. Rev. 15: 71-100.
30. HAAS, D. & S. R. GEORGE. 1988. Single and repeated mild stress increases synthesis and release of hypothalamic corticotropin-releasing factor. Brain Res. 461: 230-237.
31. ZHOU, Y., et al. 1996. Corticotropin-releasing factor and type 1 corticotropin-releasing factor receptor messenger RNAs in rat brain and pituitary during "binge"-pattern cocaine administration and chronic withdrawal. J. Exp. Pharm. Ther. 279(1): 351-358.
32. RICHTER, R. M., et al. 1995. Sensitization of cocaine-stimulated increase in extracellular levels of corticotropin-releasing factor from the rat amygdala after repeated administration as determined by intracranial microdialysis. Neurosci. Lett. 187: 169-172.
33. GAWIN, F. H. 1991. Cocaine addiction: Psychology and neurophysiology. Science 251: 1580-1586.
34. GAWIN, F. H. & E. H. ELLINWOOD. 1989. Cocaine dependence. Annu. Rev. Med. 40: 149-161.
35. GAWIN, F. H. & H. D. KLEBER. 1986. Abstinence symptomatology and psychiatric diagnosis in cocaine abusers. Arch. Gen. Psychiatry 43: 107-113.
36. NEMEROFF, C. B. 1992. New vistas in neuropeptide research in neuropsychiatry: Focus on corticotropin-releasing factor. Neuropsychopharmacology 6: 69-75.
37. GOLD, P. W., et al. 1988. Clinical and biochemical manifestations of depression: Relation to the neurobiology of stress, (second of two parts). N. Engl. J. Med. 319: 413-420.
38. GOLD, P.W., et al. 1986. Responses to corticotropin-releasing hormone in the hypercorticalism of depression and Gushing disease. Pathophysiologic and diagnostic implications. N. Engl. J. Med. 314: 1329-1335.
39. BRITTON, K. T., et al. 1985. Chlordiazepoxide attenuates response suppression induced by corticotropin-releasing factor in the conflict test. Psychopharmacology 86: 170-174.
40. CHROUSOS, G. P. & P. W. GOLD. 1992. The concepts of stress and stress system disorders. JAMA 267: 1244-1252.
41. SARNYAI, Z., et al. 1995. Brain corticotropin-releasing factor (CRF) mediates "anxiety-like" behavior induced by cocaine withdrawal in rats. Brain Res. 675: 69-77.
42. SWANSON, L. W. & D. M. SIMMONS. 1989. Differential steroid hormone and neural influences on peptide mRNA levels in CRH cells of the paraventricular nucleus: A hybridization histochemical study in the rat. J. Comp. Neurol. 285: 413-435.
43. MAKINO, S., et al. 1994. Corticosterone effects on corticotropin-releasing hormone mRNA in the central nucleus of the amygdala and the parvocellular region of the paraventricular nucleus of the hypothalamus. Brain Res. 640: 105-112.
44. GOEDERS, N. E., et al. 1990. Chronic cocaine administration alters corticotropin-releasing factor receptors in the rat brain. Brain Res. 531: 322-328.
45. RAMSEY, N. F. & J. M. VAN REE. 1993. Emotional but not physical stess enhances intravenous cocaine self-administration in drug-naive rats. Brain Res. 608: 216-222.
46. PIAZZA, P. V., et al. 1989. Factors that predict individual vulnerability to amphetamine self-administration. Science 245: 1511-1514.
47. GOEDERS, N. E. & G. F. GUERIN. 1994. Effects of adrenalectomy on intravenous cocaine self-administration. In NIDA Research Monograph Series No. 141. L. S. Harris, Ed.: 14. Government Printing Office. Washington, DC.
48. PIAZZA, P. V., et al. 1994. Inhibition of corticosterone sysnthesis by metyrapone decreases cocaine-induced locomotion and relapse of cocaine self-administration. Brain Res. 658: 259-264.
49. NOVIN, D., et al. 1995. In the activity stress paradigm (ASP) there are close relations between vital signs which allow us to predict longevity in rats with unfailing accuracy. Obesity Res. 3 (Suppl.) Abstr. 373S.
50. BERGH, C. & P. SÖDERSTEN. 1996. Anorexia nervosa, self-starvation and the reward of stress. Nature Med. 2: 21-22.
51. KUHAR M, J., et al. 1992. The dopamine hypothesis of the reinforcing properties of cocaine. Trends in Neurosci 14: 299-302.
52. FIBIGER, H. C. & A. G. PHILLIPS. 1986. Reward, motivation, cognition: psychobiology of mesotelencephalic dopamine systems. In The Handbook of Physiology, Vol. IV. Intrinsic Regulatory Systems of the Brain. V. B. Mountcastle, F. E. Bloom, S. R. Geiger Eds.: 647-675. American Physiological Society.
53. WISE, R. A. & M. A. BOZARTH. 1987. A psychomotor stimulant theory of addiction. Psychol. Rev. 94: 469-492.
54. BLOOM, F. E., et al. 1982. Corticotropin-releasing factor (CRF) immunoreactive neurones and fibers in rat hypothalamus. Reg. Pept. 4: 43-48.
55. SWANSON, L. W., et al. 1983. Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: An immunohistochemical study. Neuroendocrinology 36: 165-186.
56. HAARFSTRAND, A., et al. 1986. Glucocorticoid receptor immunoreactivity in monoaminergic neurons of rat brain, Proc. Natl. Acad. Sci. USA 83: 9779-9783.
57. ROTHSCHILD, A. J., et al. 1985. The effect of a single dose of dexamethasone on monoamine and metabolite levels in the rat brain. Life Sci. 36: 2491-2505.
58. IMPERATO, A., et al. 1989. Stress-induced enhancement of dopamine and acetylcholine release in limbic structure: Role of corticosterone. Eur. J. Pharmacol. 165: 337-339.
59. GILAD, G. M., et al. 1987. Presynaptic effects of glucocorticoids on dopaminergic and cholinergic synaptosomes. Implications for rapid endocrine-neural interactions in stress. Life Sci. 40: 2401-2408.
60. BIRON, D., et al. 1992. Effects of adrenalectomy and glucocorticoids on rat brain dopamine receptors. Neuroendocrinology 55: 468-476.
61. SARNYAI, Z., et al. 1997. Effects of adrenalectomy and corticosterone (CORT) administration on dopmaine transporter binding in the rat brain. Soc. Neurosci. Abstr. 23: 129.8.
62. KALIVAS, P. W., et al. 1989. Regulation of the mesocorticolimbic dopamine system by glutamic acid receptor subtypes. J. Pharmacol. Exp. Then 251: 378-387.
63. BIEGON, A., et al. 1985. Corticosterone modulation of neurotransmitter receptors in rat hippocampus: A quantitative autoradiographic study. Brain Res. 33: 2309-2314.
64. LING, M. H. M., et al. 1981. Side effects of corticosteroid therapy. Psychiatric aspects. Arch Gen Psychiatry 38: 471-177.
65. SARNYAI, Z., et al. 1992. The cocaine-induced elevation of plasma corticosterone is mediated by endogenous corticotropin-releasing factor (CRF) in rats. Brain Res. 589: 154-156.
66. SARNYAI, Z., et al. 1993. Cocaine-induced elevation of plasma corticosterone is mediated by different neurotransmitter sytems in rats. Pharmacol. Biochem. Behav. 25: 209-214.
67. GARDI, J., et al. 1997. Time-dependent alterations of corticotropin-releasing factor (CRF)-like immunoreactivity in different brain regions after acute cocaine administration in rats. Neuropeptides 31: 15-18.